Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Strengthening ties with Belgium ally
2013-10-31

 

From the left are: Prof Dr Johan Meeusen signing the agreement with Prof Nicky Morgan, Vice-Rector: Operations.
Photo: Hannes Pieterse
31 October 2013

The UFS signed a formal agreement with the University of Antwerp, strengthening the two institutions’ existing collaboration. Prof Dr Johan Meeusen, Vice-Rector and Professor of European Law and Private International Law at the University of Antwerp, visited the Bloemfontein Campus to sign the agreement. This arrangement will ensure that the two institutions work in close conjunction on research and additional projects.

Dineo Gaofhiwe-Ingram, Assistant Director: Internationalisation, says the new relationship between the two universities will have a strong research focus. "It’s evident and known that we want to become a research-intensive university.” She emphasises that the relationship with Antwerp as well as partnerships with a variety of other institutions are crucial. These will ensure that young emerging scholars, like those taking part in the Vice-Chancellor's Prestige Scholars Programme, are exposed internationally during their development. “We hope that some of the scholars in the new cohort of the PSP will be able to find scientists to host them at Antwerp," Gaofhiwe-Ingram adds.

In addition, she explains that this formal agreement will augment pre-existing collaborations with the Unit for Language Facilitation and Empowerment, as well as the Centre for Health Systems Research and Development. It will also open up cooperation between other faculties and disciplines. “Through Eurosa/Erasmus Mundus Project, which awards scholarships to South African students and staff to study in Europe, the 2014 project will now also award scholarships to European students and staff to come and study in South Africa,” Gaofhiwe-Ingram announced.

The University of Antwerp is one of the European associates that participates in the Leadership for Change Programme and hosted a group of first-year Kovsie students during 2011. In 2012, representatives from the University of Antwerp attended the Leadership Summit presented on the Bloemfontein Campus. Another group of first-year students from the UFS took part in this year’s programme.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept